The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease

被引:19
|
作者
Lemieux, Sarah
Ghassemi, Mehrdad
Jog, Mandar
Edwards, Roderick
Duval, Christian
机构
[1] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada
[2] Brock Univ, Fac Appl Hlth Sci, St Catharines, ON L2S 3A1, Canada
[3] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada
[4] Univ Victoria, Dept Math & Stat, Victoria, BC, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
dyskinesia; Parkinson; kinematic; treatment; levodopa; bradykinesia; manual tracking; motor overflow;
D O I
10.1007/s00221-006-0632-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The influence of peak-dose, levodopa-induced dyskinesias (LID) on manual tracking (MT) was examined in 10 dyskinetic patients with Parkinson's disease (DPD), and compared to 10 age/gender-matched non-dyskinetic patients with Parkinson's disease (NDPD) and 10 healthy controls. Whole-body movement (WBM) and MT performance were recorded simultaneously with a 6-degrees-of-freedom magnetic motion tracker and forearm rotation sensors, respectively. Subjects were asked to match the length of a computer-generated line with a line they controlled via wrist rotation. Results show that DPD patients had greater WBM magnitude at rest and during the motor task, both in displacement and in velocity. All groups displayed some increase in WBM displacement from rest to MT, but only the DPD group had a significant increase in WBM velocity during movement. As for MT performance (determined by assessing the positional mismatch between subjects' and target lines), ERROR in displacement was statistically similar between groups. There was no correlation between ERROR and the magnitude of WBM within the DPD group. The DPD group showed significant increased ERROR when the velocity of the subject's line was compared with that of the velocity of the target line. When two distinct target pace segments were examined (FAST/SLOW), no significant differences were found in ERROR for displacement for either group, but both the NDPD and DPD group showed increased ERROR from SLOW to FAST for velocity. This was accompanied with an increase in WBM velocity only in the DPD group. The lack of increased ERROR during the SLOW tracking portion in the DPD group supports the notion that the dyskinesias themselves were not primarily responsible for the ERROR seen in the patients. When examining the positive or negative values of ERROR (i.e., faster or slower than the target), we found that the increased ERROR in velocity observed in the DPD group was the result of excess velocity rather than bradykinesia, manifested as isolated deviations from the target trace in the DPD group that were coherent in time with increased ERROR in velocity. In conclusion, evidence presented in the present study shows that the LID was not the primary cause of the ERROR seen in the DPD group. Accordingly, we propose that the increased ERROR seen in the DPD group resulted from a mechanism distinct from the one generating LID.
引用
收藏
页码:465 / 475
页数:11
相关论文
共 50 条
  • [41] Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease
    Brusa, Livia
    Orlacchio, Antonio
    Stefani, Alessandro
    Galati, Salvatore
    Pierantozzi, Mariangela
    Iani, Cesare
    Mercuri, Nicola Biagio
    FUNCTIONAL NEUROLOGY, 2013, 28 (02) : 101 - 105
  • [42] Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study
    Santos-Lobato, Bruno Lopes
    Brito, Manuelina Mariana Capellari Macruz
    Pimentel, angela Vieira
    Cavalcanti, Romulo Torres Oliveira
    Del-Bel, Elaine
    Tumas, Vitor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2023, 81 (05) : 460 - 468
  • [43] Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
    Caulfield, Margaret E.
    Stancati, Jennifer A.
    Steece-Collier, Kathy
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (176):
  • [44] Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease
    Pouclet, Helene
    Derkinderen, Pascal
    Lebouvier, Thibaud
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (02) : 235 - 236
  • [45] PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease
    Pagano, Gennaro
    Yousaf, Tayyabah
    Politis, Marios
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (11)
  • [46] Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
    Voon, Valerie
    Napier, T. Celeste
    Frank, Michael J.
    Sgambato-Faure, Veronique
    Grace, Anthony A.
    Rodriguez-Oroz, Maria
    Obeso, Jose
    Bezard, Erwan
    Fernagut, Pierre-Olivier
    LANCET NEUROLOGY, 2017, 16 (03): : 238 - 250
  • [47] Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: Problems with the current model
    Obeso, JA
    Rodriguez-Oroz, MC
    Rodriguez, M
    DeLong, MR
    Olanow, CW
    ANNALS OF NEUROLOGY, 2000, 47 (04) : S22 - S34
  • [48] Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
    Calabresi, Paolo
    Di Filippo, Massimiliano
    Ghiglieri, Veronica
    Tambasco, Nicola
    Picconi, Barbara
    LANCET NEUROLOGY, 2010, 9 (11): : 1106 - 1117
  • [49] Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease
    Gour, Jackie
    Edwards, Roderick
    Lemieux, Sarah
    Ghassemi, Mehrdad
    Jog, Mandar
    Duval, Christian
    BRAIN RESEARCH BULLETIN, 2007, 74 (1-3) : 66 - 74
  • [50] Long-term evolution of levodopa-induced dyskinesias in Parkinson's disease
    Saikali, N
    Ouchchane, L
    Aublet-Cuvelier, B
    Durif, F
    NEUROLOGY, 2002, 58 (07) : A108 - A109